STOCK TITAN

[3] – Ringman Michael (CIK 0002091792)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

IBEX Ltd filed a Form 3 under Section 16(a) for its Chief Technology Officer. The filing states that no securities are beneficially owned by the reporting person. The stated event date is 10/01/2025. The form was executed by Lisa Lenstrohm as attorney-in-fact, with an attached Exhibit 24 power of attorney.

IBEX Ltd ha presentato un Modulo 3 ai sensi della Sezione 16(a) per il suo Direttore Tecnologico. La presentazione indica che nessun titolo è detenuto beneficiariamente dal soggetto segnalante. La data dell'evento dichiarata è 10/01/2025. Il modulo è stato eseguito da Lisa Lenstrohm come procuratore-in-fatto, con un allegato Esibizione 24 procura.

IBEX Ltd presentó un Formulario 3 bajo la Sección 16(a) para su Director Tecnológico. La presentación indica que ningún título está beneficiariamente poseído por la persona informante. La fecha del evento indicada es 10/01/2025. El formulario fue ejecutado por Lisa Lenstrohm como apoderada, con un Anexo 24 de poder notarial adjunto.

IBEX Ltd는 제16(a) 항에 따라 최고기술책임자(CTO)를 위한 Form 3를 제출했습니다. 제출서에 보고자는 어떤 증권도 실질적으로 소유하지 않음으로 기재되어 있습니다. 명시된 사건 날짜는 10/01/2025입니다. 양식은 Lisa Lenstrohm를 사실대리인(attorney-in-fact)으로 하여 서명되었으며, 첨부 Exhibit 24 위임장과 함께 제출되었습니다.

IBEX Ltd a déposé un Formulaire 3 en vertu de la Section 16(a) pour son Directeur Technologique. Le dépôt indique que aucun titre n'est détenu bénéficiairement par la personne déclarant. La date d'événement indiquée est 10/01/2025. Le formulaire a été signé par Lisa Lenstrohm en tant que mandataire, avec l'annexe 24 procuration jointe.

IBEX Ltd hat gemäß Abschnitt 16(a) ein Formular 3 für seinen Chief Technology Officer eingereicht. Die Einreichung besagt, dass keine Wertpapiere begünstigt von der meldenden Person gehalten werden. Das angegebene Ereignisdatum ist 10/01/2025. Das Formular wurde von Lisa Lenstrohm als Bevollmächtigte unter Vollmacht unterzeichnet, mit dem beigefügten Exhibit 24 Vollmacht.

قدمت شركة IBEX المحدودة نموذج 3 وفق القسم 16(a) لمدير التكنولوجيا التنفيذي. تنص العريضة على أن لا توجد أسهم مملوكة بشكل منتفع به من قبل الشخص المبلغ عنه. تاريخ الحدث المذكور هو 10/01/2025. وتم تنفيذ النموذج بواسطة Lisa Lenstrohm بصفتها نائباً عن الوكيل، مع الملحق 24 تفويضاً مرفقاً.

IBEX Ltd 提交了符合第16(a)条款的 Form 3,适用于其首席技术官。 申报表示,该报告人< b>并无受益所有的证券。所述事件日期为10/01/2025。该表格由Lisa Lenstrohm以代理人身份签署,附有附件 Exhibit 24 授权书。

Positive
  • None.
Negative
  • None.

IBEX Ltd ha presentato un Modulo 3 ai sensi della Sezione 16(a) per il suo Direttore Tecnologico. La presentazione indica che nessun titolo è detenuto beneficiariamente dal soggetto segnalante. La data dell'evento dichiarata è 10/01/2025. Il modulo è stato eseguito da Lisa Lenstrohm come procuratore-in-fatto, con un allegato Esibizione 24 procura.

IBEX Ltd presentó un Formulario 3 bajo la Sección 16(a) para su Director Tecnológico. La presentación indica que ningún título está beneficiariamente poseído por la persona informante. La fecha del evento indicada es 10/01/2025. El formulario fue ejecutado por Lisa Lenstrohm como apoderada, con un Anexo 24 de poder notarial adjunto.

IBEX Ltd는 제16(a) 항에 따라 최고기술책임자(CTO)를 위한 Form 3를 제출했습니다. 제출서에 보고자는 어떤 증권도 실질적으로 소유하지 않음으로 기재되어 있습니다. 명시된 사건 날짜는 10/01/2025입니다. 양식은 Lisa Lenstrohm를 사실대리인(attorney-in-fact)으로 하여 서명되었으며, 첨부 Exhibit 24 위임장과 함께 제출되었습니다.

IBEX Ltd a déposé un Formulaire 3 en vertu de la Section 16(a) pour son Directeur Technologique. Le dépôt indique que aucun titre n'est détenu bénéficiairement par la personne déclarant. La date d'événement indiquée est 10/01/2025. Le formulaire a été signé par Lisa Lenstrohm en tant que mandataire, avec l'annexe 24 procuration jointe.

IBEX Ltd hat gemäß Abschnitt 16(a) ein Formular 3 für seinen Chief Technology Officer eingereicht. Die Einreichung besagt, dass keine Wertpapiere begünstigt von der meldenden Person gehalten werden. Das angegebene Ereignisdatum ist 10/01/2025. Das Formular wurde von Lisa Lenstrohm als Bevollmächtigte unter Vollmacht unterzeichnet, mit dem beigefügten Exhibit 24 Vollmacht.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Ringman Michael

(Last) (First) (Middle)
C/O IBEX LIMITED
1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)
WASHINGTON DC 20006

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/01/2025
3. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Technology Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 - Power of Attorney
No securities are beneficially owned.
Lisa Lenstrohm, Attorney-in-Fact 10/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did IBEX (IBEX) file?

IBEX filed a Form 3, the initial statement of beneficial ownership under Section 16(a).

Whose holdings does the Form 3 cover?

It covers the company’s Chief Technology Officer as the reporting person.

What does the Form 3 report about ownership?

It states that no securities are beneficially owned by the reporting person.

What is the event date in the filing?

The event date is 10/01/2025.

Who signed the Form 3?

The form was signed by Lisa Lenstrohm as attorney-in-fact, referencing Exhibit 24 (Power of Attorney).
Ibex Ltd

NASDAQ:IBEX

IBEX Rankings

IBEX Latest News

IBEX Latest SEC Filings

IBEX Stock Data

495.59M
12.22M
13.05%
94.32%
0.95%
Information Technology Services
Services-computer Processing & Data Preparation
Link
United States
WASHINGTON